Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.

Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER.

Am J Med. 2004 Dec 15;117(12):938-47.

PMID:
15629733
2.

[Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].

Gawenda M, Möller A, Wassmer G, Brunkwall J.

Zentralbl Chir. 2007 Jun;132(3):227-31. German.

PMID:
17610195
3.
4.

N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.

Zagler A, Azadpour M, Mercado C, Hennekens CH.

Am Heart J. 2006 Jan;151(1):140-5.

PMID:
16368307
5.

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC.

Ann Intern Med. 2008 Feb 19;148(4):284-94. Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219.

PMID:
18283206
6.

The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.

Guru V, Fremes SE.

Clin Nephrol. 2004 Aug;62(2):77-83. Review.

PMID:
15356963
7.

N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.

Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF.

J Am Soc Nephrol. 2004 Mar;15(3):761-9. Review.

8.

High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy.

Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G.

Am J Med. 2009 Sep;122(9):874.e9-15. doi: 10.1016/j.amjmed.2009.01.035.

PMID:
19699385
9.

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Bagshaw SM, Ghali WA.

Arch Intern Med. 2005 May 23;165(10):1087-93. Review.

PMID:
15911721
10.

Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials.

Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z.

PLoS One. 2013;8(1):e55124. doi: 10.1371/journal.pone.0055124. Epub 2013 Jan 30.

11.

Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.

Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA.

Clin Cardiol. 2004 Nov;27(11):607-10.

12.

N-Acetylcysteine in nephrology; contrast nephropathy and beyond.

Tepel M, Zidek W.

Curr Opin Nephrol Hypertens. 2004 Nov;13(6):649-54. Review.

PMID:
15483456
13.

Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.

Pannu N, Tonelli M.

Curr Opin Nephrol Hypertens. 2006 May;15(3):285-90. Review.

PMID:
16609296
14.

Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis.

Joannidis M, Schmid M, Wiedermann CJ.

Wien Klin Wochenschr. 2008;120(23-24):742-8. doi: 10.1007/s00508-008-1117-z.

PMID:
19122985
15.

N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.

Duong MH, MacKenzie TA, Malenka DJ.

Catheter Cardiovasc Interv. 2005 Apr;64(4):471-9. Review.

PMID:
15789388
16.

N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.

Stenstrom DA, Muldoon LL, Armijo-Medina H, Watnick S, Doolittle ND, Kaufman JA, Peterson DR, Bubalo J, Neuwelt EA.

J Vasc Interv Radiol. 2008 Mar;19(3):309-18. doi: 10.1016/j.jvir.2007.11.003. Review.

PMID:
18295688
17.

Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.

Walker PD, Brokering KL, Theobald JC.

Pharmacotherapy. 2003 Dec;23(12):1617-26. Review.

PMID:
14695041
19.

Prevention of radiocontrast nephropathy.

Lin J, Bonventre JV.

Curr Opin Nephrol Hypertens. 2005 Mar;14(2):105-10. Review.

PMID:
15687835
20.

N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?

Shalansky SJ, Vu T, Pate GE, Levin A, Humphries KH, Webb JG.

Pharmacotherapy. 2005 Aug;25(8):1095-103. Review.

PMID:
16207100

Supplemental Content

Support Center